Board Member
Caribou Biosciences, Inc. (CRBU)Equibles does not estimate personal net worth.
Get an email with a short summary when Caribou Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get CRBU alertsRachel Haurwitz is recorded as CEO and Board Member at Caribou Biosciences, Inc. (CRBU). The newest filing on record that lists Rachel Haurwitz as CEO and Board Member at Caribou Biosciences, Inc. (CRBU) is dated April 24, 2026. The proxy statement of Caribou Biosciences, Inc. reports total compensation of $1,840,965 for Rachel Haurwitz in fiscal 2025, including a base salary of $667,534. Disclosed compensation is on record for 6 fiscal years. Rachel Haurwitz has spoken on 2 investor events across 1 company, most recently for Caribou Biosciences, Inc. on June 4, 2026. Caribou Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caribou Biosciences, Inc. includes Sriram Ryali (CFO), Tim Kelly (CTO), Jason V. O'Byrne (Chief Accounting Officer) and 7 others.
“Caribou is a CRISPR genome editing company at its core, and we're leveraging our proprietary home-invented CRISPR platform to develop off-the-shelf CAR T-cell therapies for patients with hematologic malignancies.”
“So Caribou is advancing two off-the-shelf CAR T-cell therapies. Vispicel targets CD19 for lymphoma and CB11 targets BCMA for multiple myeloma. Each of these programs, we shared actually quite significant clinical updates towards the end of last year.”
Start not stated–present
Last confirmed April 24, 2026
Start not stated–present
Last confirmed April 24, 2026
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Caribou Biosciences, Inc. (CRBU) | President and chief executive officer | $667,534 | $1,840,965 |
| 2024 | Caribou Biosciences, Inc. (CRBU) | President and chief executive officer | $508,733 | $4,213,245 |
| 2023 | Caribou Biosciences, Inc. (CRBU) | President and chief executive officer | $623,150 | $3,116,547 |
| 2022 | Caribou Biosciences, Inc. (CRBU) | President and chief executive officer | $513,474 | $833,468 |
| 2021 | Caribou Biosciences, Inc. (CRBU) | President and chief executive officer | $527,386 | $6,249,919 |
| 2020 | Caribou Biosciences, Inc. (CRBU) | President and chief executive officer | $450,000 | $663,900 |
